Home Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

FPG #8: Alternative Treatments in Psychiatry
FPG #7: Critical Care in Neurology
Free Medical Books

  Breast Cancer

  Free Subscription


23.01.2012

1 Am J Epidemiol
1 Ann Oncol
1 BMC Cancer
2 Br J Cancer
1 Breast Cancer
2 Breast Cancer (Auckl)
4 Breast Cancer Res
1 Breast Cancer Res Treat
1 Breast J
3 Cancer
1 Cancer Chemother Pharmacol
1 Cancer Lett
2 Clin Exp Metastasis
1 CMAJ
1 Eur J Cancer
2 Exp Cell Res
1 Int J Radiat Oncol Biol Phys
2 J Biol Chem
6 J Clin Oncol
1 J Natl Cancer Inst
2 J Nucl Med
4 J Pathol
1 J Surg Oncol
3 Lancet
1 N Engl J Med
3 Oncogene
1 Oncol Rep
1 Oncology
6 PLoS One
1 Radiother Oncol


   Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Epidemiol

  1. ANDERSON LN , Cotterchio M, Mirea L, Ozcelik H, et al
    Passive Cigarette Smoke Exposure During Various Periods of Life, Genetic Variants, and Breast Cancer Risk Among Never Smokers.
    Am J Epidemiol. 2012.
    PubMed     Text format     Related articles    Abstract available



    Ann Oncol

  2. ANDRE F , Conforti R, Moeder CB, Mauguen A, et al
    Association between the nuclear to cytoplasmic ratio of p27 and the efficacy of adjuvant polychemotherapy in early breast cancer.
    Ann Oncol. 2012.
    PubMed     Text format     Related articles    Abstract available



    BMC Cancer

  3. DE KRUIJF EM , Sajet A, van Nes JG, Putter H, et al
    NKG2D ligand tumor expression and association with clinical outcome in early breast cancer patients: an observational study.
    BMC Cancer. 2012;12:24.
    PubMed     Text format     Related articles    Abstract available



    Br J Cancer

  4. MOHAMMED ZM , McMillan DC, Elsberger B, Going JJ, et al
    Comparison of Visual and automated assessment of Ki-67 proliferative activity and their impact on outcome in primary operable invasive ductal breast cancer.
    Br J Cancer. 2012;106:383-8.
    PubMed     Text format     Related articles    Abstract available


  5. BRAIN E , Isambert N, Dalenc F, Dieras V, et al
    Phase I study of lapatinib plus vinorelbine in patients with locally advanced or metastatic breast cancer overexpressing HER2.
    Br J Cancer. 2012 Jan 12. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available



    Breast Cancer

  6. SHIOZAWA M , Lefor AT, Hozumi Y, Kurihara K, et al
    Sentinel lymph node biopsy in patients with breast cancer using superparamagnetic iron oxide and a magnetometer.
    Breast Cancer. 2012.
    PubMed     Text format     Related articles    Abstract available



    Breast Cancer (Auckl)

  7. JIN H , Yu Y, Chrisler WB, Xiong Y, et al
    Delivery of MicroRNA-10b with Polylysine Nanoparticles for Inhibition of Breast Cancer Cell Wound Healing.
    Breast Cancer (Auckl). 2012;6:9-19.
    PubMed     Text format     Related articles    Abstract available


  8. QI JP , Yang YL, Zhu H, Wang J, et al
    Expression of the androgen receptor and its correlation with molecular subtypes in 980 chinese breast cancer patients.
    Breast Cancer (Auckl). 2012;6:1-8.
    PubMed     Text format     Related articles    Abstract available



    Breast Cancer Res

  9. KIM SJ , Shin JY, Lee KD, Bae YK, et al
    MicroRNA let-7a suppresses breast cancer cell migration and invasion through down-regulation of C-C chemokine receptor type 7.
    Breast Cancer Res. 2012;14:R14.
    PubMed     Text format     Related articles    Abstract available


  10. BUNDRED NJ , Kenemans P, Yip CH, Beckmann MW, et al
    Tibolone increases bone mineral density but also relapse in breast cancer survivors: LIBERATE Trial Bone Sub-study.
    Breast Cancer Res. 2012;14:R13.
    PubMed     Text format     Related articles    Abstract available


  11. LAPPANO R , Santolla MF, Pupo M, Sinicropi MS, et al
    MIBE acts as antagonist ligand of both estrogen receptor alpha and GPER in breast cancer cells.
    Breast Cancer Res. 2012;14:R12.
    PubMed     Text format     Related articles    Abstract available


  12. REYAL F , Guyader C, Decraene C, Lucchesi C, et al
    Molecular profiling of patient-derived breast cancer xenografts.
    Breast Cancer Res. 2012;14:R11.
    PubMed     Text format     Related articles    Abstract available



    Breast Cancer Res Treat

  13. FLEMING GF , Ma CX, Huo D, Sattar H, et al
    Phase II trial of temsirolimus in patients with metastatic breast cancer.
    Breast Cancer Res Treat. 2012.
    PubMed     Text format     Related articles    Abstract available



    Breast J

  14. STAHL MS , Prichard J, Stark A
    Adiposity and Risk of Proliferative Diseases of the Breast Prior to the Diagnosis of Invasive Breast Cancer: Results from a Pilot Study.
    Breast J. 2012 Jan 12. doi: 10.1111/j.1524-4741.2011.01213.
    PubMed     Text format     Related articles   



    Cancer

  15. PAXTON RJ , Phillips KL, Jones LA, Chang S, et al
    Associations among physical activity, body mass index, and health-related quality of life by race/ethnicity in a diverse sample of breast cancer survivors.
    Cancer. 2012 Jan 17. doi: 10.1002/cncr.27389.
    PubMed     Text format     Related articles    Abstract available


  16. ISHITOBI M , Ohsumi S, Inaji H, Ohno S, et al
    Ipsilateral breast tumor recurrence (IBTR) in patients with operable breast cancer who undergo breast-conserving treatment after receiving neoadjuvant chemotherapy: Risk factors of IBTR and validation of the M. D. Anderson Prognostic Index.
    Cancer. 2012 Jan 17. doi: 10.1002/cncr.27377.
    PubMed     Text format     Related articles    Abstract available


  17. TAMAKI Y , Sato N, Homma K, Takabatake D, et al
    Routine clinical use of the one-step nucleic acid amplification assay for detection of sentinel lymph node metastases in breast cancer patients: Results of a multicenter study in Japan.
    Cancer. 2012 Jan 17. doi: 10.1002/cncr.26683.
    PubMed     Text format     Related articles    Abstract available



    Cancer Chemother Pharmacol

  18. WALKO CM , Combest AJ, Spasojevic I, Yu AY, et al
    The effect of aprepitant and race on the pharmacokinetics of cyclophosphamide in breast cancer patients.
    Cancer Chemother Pharmacol. 2012.
    PubMed     Text format     Related articles    Abstract available



    Cancer Lett

  19. NAOI Y , Tanei T, Kishi K, Tsunashima R, et al
    70-Gene classifier for differentiation between paclitaxel- and docetaxel-sensitive breast cancers.
    Cancer Lett. 2012;314:206-12.
    PubMed     Text format     Related articles    Abstract available



    Clin Exp Metastasis

  20. BRETZ N , Noske A, Keller S, Erbe-Hofmann N, et al
    CD24 promotes tumor cell invasion by suppressing tissue factor pathway inhibitor-2 (TFPI-2) in a c-Src-dependent fashion.
    Clin Exp Metastasis. 2012;29:27-38.
    PubMed     Text format     Related articles    Abstract available


  21. CHAO Y , Wu Q, Shepard C, Wells A, et al
    Hepatocyte induced re-expression of E-cadherin in breast and prostate cancer cells increases chemoresistance.
    Clin Exp Metastasis. 2012;29:39-50.
    PubMed     Text format     Related articles    Abstract available



    CMAJ

  22. GOTZSCHE PC
    Time to stop mammography screening?
    CMAJ. 2011;183:1957-8.
    PubMed     Text format     Related articles   



    Eur J Cancer

  23. MILES D , Zielinski C, Martin M, Vrdoljak E, et al
    Combining capecitabine and bevacizumab in metastatic breast cancer: A comprehensive review.
    Eur J Cancer. 2012.
    PubMed     Text format     Related articles    Abstract available



    Exp Cell Res

  24. KARAM M , Legay C, Auclair C, Ricort JM, et al
    Protein kinase D1 stimulates proliferation and enhances tumorigenesis of MCF-7 human breast cancer cells through a MEK/ERK-dependent signaling pathway.
    Exp Cell Res. 2012.
    PubMed     Text format     Related articles    Abstract available


  25. SULTANA R , Theodoraki MA, Caplan AJ
    UBR1 promotes protein kinase quality control and sensitizes cells to Hsp90 inhibition.
    Exp Cell Res. 2012;318:53-60.
    PubMed     Text format     Related articles    Abstract available



    Int J Radiat Oncol Biol Phys

  26. HYMAS RV , Gaffney DK, Parkinson BT, Belnap TW, et al
    Is Short-Interval Mammography Necessary after Breast Conservation Surgery and Radiation Treatment in Breast Cancer Patients?
    Int J Radiat Oncol Biol Phys. 2012.
    PubMed     Text format     Related articles    Abstract available



    J Biol Chem

  27. CHAUDHRI RA , Olivares-Navarrete R, Cuenca N, Hadadi A, et al
    Membrane estrogen signaling enhances tumorigenesis and metastatic potential of breast cancer cells via estrogen receptor-alpha36 (ERalpha36).
    J Biol Chem. 2012.
    PubMed     Text format     Related articles    Abstract available


  28. MITRA D , Das PM, Huynh FC, Jones FE, et al
    Jumonji/ARID1 B (JARID1B) protein promotes breast tumor cell cycle progression through epigenetic repression of microRNA let-7e.
    J Biol Chem. 2011;286:40531-5.
    PubMed     Text format     Related articles    Abstract available



    J Clin Oncol

  29. YI M , Meric-Bernstam F, Kuerer HM, Mittendorf EA, et al
    Evaluation of a Breast Cancer Nomogram for Predicting Risk of Ipsilateral Breast Tumor Recurrences in Patients With Ductal Carcinoma in Situ After Local Excision.
    J Clin Oncol. 2012.
    PubMed     Text format     Related articles    Abstract available


  30. BRAUCH HB , Schroth W, Ingle JN, Goetz MP, et al
    CYP2D6 and tamoxifen: awaiting the denouement.
    J Clin Oncol. 2011;29:4589-90.
    PubMed     Text format     Related articles   


  31. ROBSON M
    Do women remain at risk even if they do not inherit a familial BRCA1/2 mutation?
    J Clin Oncol. 2011;29:4477-8.
    PubMed     Text format     Related articles   


  32. HAFFTY BG , Hunt KK, Harris JR, Buchholz TA, et al
    Positive sentinel nodes without axillary dissection: implications for the radiation oncologist.
    J Clin Oncol. 2011;29:4479-81.
    PubMed     Text format     Related articles   


  33. GONZALEZ-ANGULO AM , Hortobagyi GN
    Is there an ideal way to combine trastuzumab with chemotherapy?
    J Clin Oncol. 2011;29:4474-6.
    PubMed     Text format     Related articles   


  34. BASILE FG , Creamer S
    Docetaxel/Cyclophosphamide-induced ultraviolet recall dermatitis.
    J Clin Oncol. 2011;29:e840-1.
    PubMed     Text format     Related articles   



    J Natl Cancer Inst

  35. SPARANO JA , Wang M, Zhao F, Stearns V, et al
    Race and Hormone Receptor-Positive Breast Cancer Outcomes in a Randomized Chemotherapy Trial.
    J Natl Cancer Inst. 2012.
    PubMed     Text format     Related articles    Abstract available



    J Nucl Med

  36. GROHEUX D , Hindie E, Giacchetti S, Delord M, et al
    Triple-Negative Breast Cancer: Early Assessment with 18F-FDG PET/CT During Neoadjuvant Chemotherapy Identifies Patients Who Are Unlikely to Achieve a Pathologic Complete Response and Are at a High Risk of Early Relapse.
    J Nucl Med. 2012.
    PubMed     Text format     Related articles    Abstract available


  37. VAN KRUCHTEN M , Glaudemans AW, de Vries EF, Beets-Tan RG, et al
    PET Imaging of Estrogen Receptors as a Diagnostic Tool for Breast Cancer Patients Presenting with a Clinical Dilemma.
    J Nucl Med. 2012.
    PubMed     Text format     Related articles    Abstract available



    J Pathol

  38. CHEN SC , Kung ML, Hu TH, Chen HY, et al
    Hepatoma-Derived Growth Factor Regulates breast cancer cell invasion by Modulating Epithelial Mesenchymal Transition.
    J Pathol. 2012 Jan 13. doi: 10.1002/path.3988.
    PubMed     Text format     Related articles    Abstract available


  39. WETTERSKOG D , Lopez-Garcia MA, Lambros MB, A'Hern R, et al
    Adenoid cystic carcinomas constitute a genomically distinct subgroup of triple-negative and basal-like breast cancers.
    J Pathol. 2012;226:84-96.
    PubMed     Text format     Related articles    Abstract available


  40. G GRITSENKO P , Ilina O, Friedl P
    Interstitial guidance of cancer invasion.
    J Pathol. 2012;226:185-99.
    PubMed     Text format     Related articles    Abstract available


  41. GIRICZ O , Reynolds PA, Ramnauth A, Liu C, et al
    Hsa-miR-375 is differentially expressed during breast lobular neoplasia and promotes loss of mammary acinar polarity.
    J Pathol. 2012;226:108-19.
    PubMed     Text format     Related articles    Abstract available



    J Surg Oncol

  42. RUBIO IT , Cebrecos I, Peg V, Esgueva A, et al
    Extensive nodal involvement increases the positivity of blue nodes in the axillary reverse mapping procedure in patients with breast cancer.
    J Surg Oncol. 2012 Jan 18. doi: 10.1002/jso.23048.
    PubMed     Text format     Related articles    Abstract available



    Lancet

  43. BASELGA J , Bradbury I, Eidtmann H, Di Cosimo S, et al
    Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial.
    Lancet. 2012.
    PubMed     Text format     Related articles    Abstract available


  44. GNANT M , Steger GG
    Dual inhibition of HER2 in breast cancer treatment.
    Lancet. 2012.
    PubMed     Text format     Related articles   


  45. GOTZSCHE PC , Jorgensen KJ
    Effect of population-based screening on breast cancer mortality.
    Lancet. 2012.
    PubMed     Text format     Related articles   



    N Engl J Med

  46. GRADISHAR WJ
    HER2 therapy--an abundance of riches.
    N Engl J Med. 2012;366:176-8.
    PubMed     Text format     Related articles   



    Oncogene

  47. NIEMELA M , Kauko O, Sihto H, Mpindi JP, et al
    CIP2A signature reveals the MYC dependency of CIP2A-regulated phenotypes and its clinical association with breast cancer subtypes.
    Oncogene. 2012 Jan 16. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available


  48. CUTRUPI S , Reineri S, Panetto A, Grosso E, et al
    Targeting of the adaptor protein Tab2 as a novel approach to revert tamoxifen resistance in breast cancer cells.
    Oncogene. 2012 Jan 16. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available


  49. WANG J , Ray PS, Sim MS, Zhou XZ, et al
    FOXC1 regulates the functions of human basal-like breast cancer cells by activating NF-kappaB signaling.
    Oncogene. 2012 Jan 16. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available



    Oncol Rep

  50. ZHENG SR , Guo GL, Zhang W, Huang GL, et al
    Clinical significance of miR-155 expression in breast cancer and effects of miR-155 ASO on cell viability and apoptosis.
    Oncol Rep. 2012 Jan 12. doi: 10.3892/or.2012.1634.
    PubMed     Text format     Related articles    Abstract available



    Oncology

  51. MATSUBARA N , Mukai H, Itoh K, Nagai S, et al
    Prognostic Impact of Ki-67 Overexpression in Subgroups Categorized according to St. Gallen with Early Stage Breast Cancer.
    Oncology. 2012;81.
    PubMed     Text format     Related articles    Abstract available



    PLoS One

  52. SUN B , Liu R, Xiao ZD, Zhu X, et al
    c-MET Protects Breast Cancer Cells from Apoptosis Induced by Sodium Butyrate.
    PLoS One. 2012;7:e30143.
    PubMed     Text format     Related articles    Abstract available


  53. WENDEL C , Hemping-Bovenkerk A, Krasnyanska J, Mees ST, et al
    CXCR4/CXCL12 Participate in Extravasation of Metastasizing Breast Cancer Cells within the Liver in a Rat Model.
    PLoS One. 2012;7:e30046.
    PubMed     Text format     Related articles    Abstract available


  54. ZHANG CY , Chen J, Yin DC, Lin SX, et al
    The contribution of 17beta-hydroxysteroid dehydrogenase type 1 to the estradiol-estrone ratio in estrogen-sensitive breast cancer cells.
    PLoS One. 2012;7:e29835.
    PubMed     Text format     Related articles    Abstract available


  55. SHAH M , Huang D, Blick T, Connor A, et al
    An MMP13-Selective Inhibitor Delays Primary Tumor Growth and the Onset of Tumor-Associated Osteolytic Lesions in Experimental Models of Breast Cancer.
    PLoS One. 2012;7:e29615.
    PubMed     Text format     Related articles    Abstract available


  56. SCHRAUDER MG , Strick R, Schulz-Wendtland R, Strissel PL, et al
    Circulating Micro-RNAs as Potential Blood-Based Markers for Early Stage Breast Cancer Detection.
    PLoS One. 2012;7:e29770.
    PubMed     Text format     Related articles    Abstract available


  57. HUANG S , Ouyang N, Lin L, Chen L, et al
    HGF-Induced PKCzeta Activation Increases Functional CXCR4 Expression in Human Breast Cancer Cells.
    PLoS One. 2012;7:e29124.
    PubMed     Text format     Related articles    Abstract available



    Radiother Oncol

  58. TERRAZZINO S , Mattina PL, Masini L, Caltavuturo T, et al
    Common variants of eNOS and XRCC1 genes may predict acute skin toxicity in breast cancer patients receiving radiotherapy after breast conserving surgery.
    Radiother Oncol. 2012.
    PubMed     Text format     Related articles    Abstract available



Thank you for your interest in scientific medicine.


Amedeo is a Flying Publisher website.

   Design: